Dr. Wisit Cheungpasitporn, MD

Dr. Cheungpasitporn practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Cheungpasitporn's NPI, 1114248424, was assigned on June 21, 2010. Dr. Cheungpasitporn holds Minnesota license 56833.

Dr. Cheungpasitporn's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Dr. Cheungpasitporn's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dr. Cheungpasitporn is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Cheungpasitporn to 1 more hospital, 6 medical groups, 1 clinical lab and 1 hospice, each named with a free account. Dr. Cheungpasitporn's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheungpasitporn practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Cheungpasitporn's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Cheungpasitporn's licenses on file in 2 states: Minnesota and Mississippi.

CMS data shows 594 Medicare services from Dr. Cheungpasitporn across 8 procedure codes in 2024, for 382 Medicare patients. Medicare paid $54,348 for them.

CMS counts 382 Medicare patients who saw Dr. Cheungpasitporn in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 13% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheungpasitporn's median patient age at 72, with 48% women.

In 2024, Dr. Cheungpasitporn wrote 501 Medicare Part D claims for 122 patients. 88% of them were for generic drugs. CMS names the drug for 319 of them, across 13 drugs with 11 or more claims each, at $213,153 in total drug cost. In 2023, CMS named 365 claims across 14 drugs.

Dr. Cheungpasitporn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cheungpasitporn as offering telehealth.

Dmand AI links 595 papers to Dr. Cheungpasitporn, published from 2011 to 2025. 2020 was the busiest year, with 91. The most frequent topics are Kidney Transplantation, Hospital Mortality and Acute Kidney Injury. Dr. Cheungpasitporn has published most often in J Clin Med. Dr. Cheungpasitporn's most frequent co-authors are Charat Thongprayoon, MD, Michael A. Mao, MD and Patompong Ungprasert, MD.

CMS Open Payments shows 2 general payments to Dr. Cheungpasitporn from 2 drug and device companies from 2018 to 2019. Food and beverage make up the largest share, 57% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $97.